TrialCancer chemotherapy and pharmacology2023

Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer.

Loek A W de Jong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.